Abstract
Suicidal thoughts and behaviors (STB) rank among the foremost causes of death globally. While literature consistently highlights heightened risk behavior in individuals with STB and identifies mood issues as central to STB, the precise cognitive and affective computational mechanisms driving this increased risky behavior remain elusive. Here, we asked 83 adolescent inpatients with affective disorders, where 58 patients with STB (S+) and 25 without STB (S-), and 118 gender/age-matched healthy control (HC) to make decisions between certain vs. gamble option with momentary mood ratings. Choice data analyses revealed heightened risk behavior in S+ compared to S- and HC. Using a prospect theory model enhanced with approach-avoidance Pavlovian parameters revealed that this rise in risky behavior resulted only from a heightened Pavlovian approach parameter in S+. Furthermore, Pavlovian approach mediated the rise in gambling choices with STB severity. Altogether, model-based choice data analysis indicated dysfunction in the Pavlovian approach system in S+ individuals, leading to greater propensity for gambling in favorable outcomes regardless the lotteries expected value. Additionally, mood model-based analyses revealed reduced sensitivity to certain rewards in S+ compared to S- and HC. Importantly, these computational markers generalized to healthy population (n □ = □ 747). In S+, mood sensitivity to certain reward was negatively correlated with gambling, offering a mood computational account for increased risk behavior in STB. These findings remained significant even after adjusting for demographic, clinical, and medication-related variables. Overall, our study uncovers the cognitive and affective mechanisms contributing to increased risk behavior in STB, with significant implications for suicide prevention.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Natural Science Foundation of China
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethical committee of The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We have made significant improvements to our study. We have collected data from an additional 747 healthy control participants to replicate our previous computational markers for suicidal thoughts and behaviour (now the total N = 948), thereby substantially increasing the robustness of our findings. Moreover, we have conducted several new analyses to further strengthen our paper, including controls for potential clinical and medication-related confounds.